178 related articles for article (PubMed ID: 33402842)
1. Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection.
Chen HW; Chiu YL; Hsieh TY; Chen PJ; Huang TY; Lin HH; Shih YL; Lin JC
J Inflamm Res; 2020; 13():1207-1218. PubMed ID: 33402842
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection.
Kitson MT; Dore GJ; George J; Button P; McCaughan GW; Crawford DH; Sievert W; Weltman MD; Cheng WS; Roberts SK
J Hepatol; 2013 Mar; 58(3):467-72. PubMed ID: 23183524
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C.
Arai T; Atsukawa M; Tsubota A; Kondo C; Shimada N; Abe H; Itokawa N; Nakagawa A; Okubo T; Aizawa Y; Iwakiri K
J Med Virol; 2015 Nov; 87(11):1904-12. PubMed ID: 25964133
[TBL] [Abstract][Full Text] [Related]
4. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin.
Atsukawa M; Tsubota A; Shimada N; Yoshizawa K; Abe H; Asano T; Ohkubo Y; Araki M; Ikegami T; Okubo T; Kondo C; Osada Y; Nakatsuka K; Chuganji Y; Matsuzaki Y; Iwakiri K; Aizawa Y
Hepatol Res; 2016 Mar; 46(5):450-8. PubMed ID: 26289410
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis.
Kitson MT; Sarrazin C; Toniutto P; Eslick GD; Roberts SK
J Hepatol; 2014 Dec; 61(6):1247-52. PubMed ID: 25135863
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
[TBL] [Abstract][Full Text] [Related]
7. 25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients.
Belle A; Gizard E; Conroy G; Lopez A; Bouvier-Alias M; Rouanet S; Peyrin-Biroulet L; Pawlotsky JM; Bronowicki JP
United European Gastroenterol J; 2017 Feb; 5(1):69-75. PubMed ID: 28405324
[TBL] [Abstract][Full Text] [Related]
8. Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C.
El-Derany MO; Hamdy NM; Al-Ansari NL; El-Mesallamy HO
BMC Gastroenterol; 2016 Feb; 16():19. PubMed ID: 26911666
[TBL] [Abstract][Full Text] [Related]
9. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients.
Baur K; Mertens JC; Schmitt J; Iwata R; Stieger B; Frei P; Seifert B; Bischoff Ferrari HA; von Eckardstein A; Müllhaupt B; Geier A;
Antivir Ther; 2012; 17(3):541-7. PubMed ID: 22300961
[TBL] [Abstract][Full Text] [Related]
10. A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.
Lange CM; Bibert S; Kutalik Z; Burgisser P; Cerny A; Dufour JF; Geier A; Gerlach TJ; Heim MH; Malinverni R; Negro F; Regenass S; Badenhoop K; Bojunga J; Sarrazin C; Zeuzem S; Müller T; Berg T; Bochud PY; Moradpour D;
PLoS One; 2012; 7(7):e40159. PubMed ID: 22808108
[TBL] [Abstract][Full Text] [Related]
11. Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/ribavirin-based therapy in Egyptian patients with chronic hepatitis C.
Abdelsalam A; Rashed L; Salman T; Hammad L; Sabry D
J Dig Dis; 2016 Aug; 17(8):547-553. PubMed ID: 27128845
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children.
El Naghi S; Abdel-Ghaffar TY; El-Karaksy H; Abdel-Aty EF; El-Raziky MS; Allam AA; Helmy H; El-Araby HA; Behairy BE; El-Guindi MA; El-Sebaie H; Abdel-Ghaffar AY; Ehsan NA; El-Hennawy AM; Sira MM
World J Gastroenterol; 2014 Apr; 20(16):4681-91. PubMed ID: 24782620
[TBL] [Abstract][Full Text] [Related]
13. Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.
Younossi ZM; McCullough AC; Barnes DS; Post A; Ong JP; O'Shea R; Martin LM; Bringman D; Farmer D; Levinthal G; Mullen KD; Carey WD; Tavill AS; Ferguson R; Gramlich T
Dig Dis Sci; 2005 May; 50(5):970-5. PubMed ID: 15906777
[TBL] [Abstract][Full Text] [Related]
14. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.
Petta S; Cammà C; Scazzone C; Tripodo C; Di Marco V; Bono A; Cabibi D; Licata G; Porcasi R; Marchesini G; Craxí A
Hepatology; 2010 Apr; 51(4):1158-67. PubMed ID: 20162613
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India.
Behera MK; Shukla SK; Dixit VK; Nath P; Abhilash VB; Asati PK; Jain AK
Indian J Med Res; 2018 Aug; 148(2):200-206. PubMed ID: 30381543
[TBL] [Abstract][Full Text] [Related]
16. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis.
García-Álvarez M; Pineda-Tenor D; Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; Resino S
Hepatology; 2014 Nov; 60(5):1541-50. PubMed ID: 24975775
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients.
Abu-Mouch S; Fireman Z; Jarchovsky J; Zeina AR; Assy N
World J Gastroenterol; 2011 Dec; 17(47):5184-90. PubMed ID: 22215943
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C.
Petta S; Ferraro D; Cammà C; Cabibi D; Di Cristina A; Di Marco V; Di Stefano R; Grimaudo S; Mazzola A; Levrero M; Scazzone C; Craxì A
Antivir Ther; 2012; 17(5):823-31. PubMed ID: 22505587
[TBL] [Abstract][Full Text] [Related]
19. [Dynamic changes in PD-1, TLR3, and TLR4 surface expression on peripheral blood mononuclear cells in chronic hepatitis C patients undergoing peg-IFNalpha-2a plus ribavirin combination therapy].
Zhang M; Jiang YF; Xiao XQ; Liu SF; Peng ML; Liu D; Gong GZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):196-201. PubMed ID: 23967741
[TBL] [Abstract][Full Text] [Related]
20. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
Mandorfer M; Reiberger T; Payer BA; Ferlitsch A; Breitenecker F; Aichelburg MC; Obermayer-Pietsch B; Rieger A; Trauner M; Peck-Radosavljevic M;
AIDS; 2013 Jan; 27(2):227-32. PubMed ID: 23238552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
